Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?

Keijsers RGM, Grutters JC.

J Clin Med. 2020 Mar 24;9(3). pii: E890. doi: 10.3390/jcm9030890. Review.

2.

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.

Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Ennis James W 4th, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Müller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand MB.

Eur Respir Rev. 2020 Mar 20;29(155). pii: 190146. doi: 10.1183/16000617.0146-2019. Print 2020 Mar 31. Review.

3.

Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets.

Schreurs I, Meek B, Hijdra D, van Moorsel CHM, Luijk HD, Kwakkel-van Erp JM, Oudijk E, van Kessel DA, Grutters JC.

Transplant Proc. 2020 Mar 4. pii: S0041-1345(19)31035-8. doi: 10.1016/j.transproceed.2020.01.012. [Epub ahead of print]

PMID:
32146023
4.

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review.

Vis R, van de Garde EMW, Grutters JC, Korenromp IHE.

Eur Respir Rev. 2020 Jan 29;29(155). pii: 190057. doi: 10.1183/16000617.0057-2019. Print 2020 Mar 31. Review.

5.

Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis.

Moll SA, Wiertz IA, Vorselaars ADM, Ruven HJT, van Moorsel CHM, Grutters JC.

Lung. 2020 Jan 28. doi: 10.1007/s00408-020-00330-9. [Epub ahead of print]

PMID:
31993739
6.

[89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study.

Adams H, van de Garde EM, van Moorsel CH, Vugts DJ, van Dongen GA, Grutters JC, Keijsers RG.

Am J Nucl Med Mol Imaging. 2019 Dec 15;9(6):296-308. eCollection 2019.

7.

The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis.

Platenburg MGJP, Wiertz IA, van der Vis JJ, Crestani B, Borie R, Dieude P, Kannengiesser C, Burgers JA, Grutters JC, van Moorsel CHM.

Eur Respir J. 2020 Jan 16. pii: 1902361. doi: 10.1183/13993003.02361-2019. [Epub ahead of print] No abstract available.

PMID:
31949121
8.

From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.

van Batenburg AA, Kazemier KM, van Oosterhout MFM, van der Vis JJ, van Es HW, Grutters JC, Goldschmeding R, van Moorsel CHM.

PLoS One. 2020 Jan 7;15(1):e0226785. doi: 10.1371/journal.pone.0226785. eCollection 2020.

9.

Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation.

Sikma MA, Van Maarseveen EM, Hunault CC, Moreno JM, Van de Graaf EA, Kirkels JH, Verhaar MC, Grutters JC, Kesecioglu J, De Lange DW, Huitema ADR.

Clin Pharmacokinet. 2019 Dec 16. doi: 10.1007/s40262-019-00854-1. [Epub ahead of print]

PMID:
31840222
10.

High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation.

Sikma MA, Hunault CC, Van Maarseveen EM, Huitema ADR, Van de Graaf EA, Kirkels JH, Verhaar MC, Grutters JC, Kesecioglu J, De Lange DW.

Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):123-134. doi: 10.1007/s13318-019-00591-7.

11.

Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes.

Kampstra NA, van der Nat PB, Dijksman LM, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Zanen P, Wijsenbeek MS, Eijkemans MJC, Biesma DH, van der Wees PJ, Grutters JC.

ERJ Open Res. 2019 Oct 30;5(4). pii: 00094-2019. doi: 10.1183/23120541.00094-2019. eCollection 2019 Oct.

12.

Pulmonary fibrosis linked to variants in the ACD gene, encoding the telomere protein TPP1.

Hoffman TW, van der Vis JJ, van der Smagt JJ, Massink MPG, Grutters JC, van Moorsel CHM.

Eur Respir J. 2019 Dec 19;54(6). pii: 1900809. doi: 10.1183/13993003.00809-2019. Print 2019 Dec. No abstract available.

PMID:
31515401
13.

Clustering of immune-mediated diseases in sarcoidosis.

Terwiel M, Grutters JC, van Moorsel CHM.

Curr Opin Pulm Med. 2019 Sep;25(5):539-553. doi: 10.1097/MCP.0000000000000598.

PMID:
31365389
14.

Patient perspectives in sarcoidosis.

van Helmondt SJ, Polish LB, Judson MA, Grutters JC.

Curr Opin Pulm Med. 2019 Sep;25(5):478-483. doi: 10.1097/MCP.0000000000000602.

PMID:
31365382
15.

Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane.

Willemsen AECAB, Tol J, van Erp NP, Jonker MA, de Boer M, Meek B, de Jong PC, van Moorsel C, Gerritsen WR, Grutters JC, van Herpen CML.

Target Oncol. 2019 Aug;14(4):441-451. doi: 10.1007/s11523-019-00656-2.

16.

Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study.

Huitema MP, Bakker ALM, Mager JJ, Rensing BJWM, Smits F, Snijder RJ, Grutters JC, Post MC.

Eur Respir J. 2019 Oct 31;54(4). pii: 1900897. doi: 10.1183/13993003.00897-2019. Print 2019 Oct. No abstract available.

PMID:
31320453
17.

Publisher Correction: Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 16;5(1):49. doi: 10.1038/s41572-019-0107-y.

PMID:
31311930
18.

Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 4;5(1):45. doi: 10.1038/s41572-019-0096-x. Review. Erratum in: Nat Rev Dis Primers. 2019 Jul 16;5(1):49.

PMID:
31273209
19.

Patient perspectives in sarcoidosis.

van Helmondt SJ, Polish LB, Judson MA, Grutters JC.

Curr Opin Pulm Med. 2019 Jun 24. doi: 10.1097/MCP.0000000000000602. [Epub ahead of print]

PMID:
31246592
20.

Clustering of immune-mediated diseases in sarcoidosis.

Terwiel M, Grutters JC, van Moorsel CHM.

Curr Opin Pulm Med. 2019 Jun 18. doi: 10.1097/MCP.0000000000000598. [Epub ahead of print]

PMID:
31219835
21.

The extent of microbiological testing is associated with alteration of antibiotic therapy in adults with community-acquired pneumonia.

Wittermans E, Vestjens SMT, Bos WJW, Grutters JC, van de Garde EMW, Vlaminckx BJM.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1359-1366. doi: 10.1007/s10096-019-03561-8. Epub 2019 Apr 25.

PMID:
31025133
22.

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Kampstra NA, Grutters JC, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Wijsenbeek MS, Biesma DH, van der Wees PJ, van der Nat PB.

BMJ Open Respir Res. 2019 Feb 18;6(1):e000394. doi: 10.1136/bmjresp-2018-000394. eCollection 2019.

23.

Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia.

Vestjens SMT, Wittermans E, Spoorenberg SMC, Grutters JC, van Ruitenbeek CA, Voorn GP, Bos WJW, van de Garde EMW.

Pneumonia (Nathan). 2018 Dec 25;10:15. doi: 10.1186/s41479-018-0059-0. eCollection 2018.

24.

Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.

Karakaya B, Schimmelpennink MC, Kocourkova L, van der Vis JJ, Meek B, Grutters JC, Petrek M, van Moorsel CHM.

Clin Exp Immunol. 2019 May;196(2):249-258. doi: 10.1111/cei.13257. Epub 2019 Jan 24.

PMID:
30585624
25.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

26.

Systematic review of drug effects in humans and models with surfactant-processing disease.

Klay D, Hoffman TW, Harmsze AM, Grutters JC, van Moorsel CHM.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 170135. doi: 10.1183/16000617.0135-2017. Print 2018 Sep 30.

27.

Transbronchial Cryobiopsy for Interstitial Lung Disease: Is it too Late to Put the Toothpaste Back in the Tube?

Culver DA, Grutters JC.

J Bronchology Interv Pulmonol. 2018 Apr;25(2):85-87. doi: 10.1097/LBR.0000000000000487. No abstract available.

PMID:
29561394
28.

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.

de Brouwer B, Drent M, van den Ouweland JMW, Wijnen PA, van Moorsel CHM, Bekers O, Grutters JC, White ES, Janssen R.

Respir Res. 2018 Mar 20;19(1):45. doi: 10.1186/s12931-018-0747-6.

29.

Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.

Snetselaar R, van Oosterhout MFM, Grutters JC, van Moorsel CHM.

Front Med (Lausanne). 2018 Feb 27;5:41. doi: 10.3389/fmed.2018.00041. eCollection 2018.

30.

Cell Type-Specific Quantification of Telomere Length and DNA Double-strand Breaks in Individual Lung Cells by Fluorescence In Situ Hybridization and Fluorescent Immunohistochemistry.

van Batenburg AA, Kazemier KM, Peeters T, van Oosterhout MFM, van der Vis JJ, Grutters JC, Goldschmeding R, van Moorsel CHM.

J Histochem Cytochem. 2018 Jul;66(7):485-495. doi: 10.1369/0022155418761351. Epub 2018 Mar 12.

31.

Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF).

Wiertz IA, van Moorsel CHM, Vorselaars ADM, Quanjel MJR, Grutters JC.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702519. doi: 10.1183/13993003.02519-2017. Print 2018 Apr. No abstract available.

32.

Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.

Spoorenberg SMC, Vestjens SMT, Voorn GP, van Moorsel CHM, Meek B, Zanen P, Rijkers GT, Bos WJW, Grutters JC; Ovidius study group.

PLoS One. 2018 Jan 11;13(1):e0190575. doi: 10.1371/journal.pone.0190575. eCollection 2018.

33.

Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

De Brouwer B, Piscaer I, Von Der Thusen JH, Grutters JC, Schutgens RE, Wouters EF, Janssen R.

Expert Rev Respir Med. 2018 Mar;12(3):169-175. doi: 10.1080/17476348.2018.1424544. Epub 2018 Jan 9.

PMID:
29303380
34.

Short telomere length in IPF lung associates with fibrotic lesions and predicts survival.

Snetselaar R, van Batenburg AA, van Oosterhout MFM, Kazemier KM, Roothaan SM, Peeters T, van der Vis JJ, Goldschmeding R, Grutters JC, van Moorsel CHM.

PLoS One. 2017 Dec 27;12(12):e0189467. doi: 10.1371/journal.pone.0189467. eCollection 2017.

35.

Clubbing in patients with fibrotic interstitial lung diseases.

van Manen MJG, Vermeer LC, Moor CC, Vrijenhoeff R, Grutters JC, Veltkamp M, Wijsenbeek MS.

Respir Med. 2017 Nov;132:226-231. doi: 10.1016/j.rmed.2017.10.021. Epub 2017 Nov 2.

36.

Unfavourable outcome of glucocorticoid treatment in suspected idiopathic pulmonary fibrosis.

Wiertz IA, Wuyts WA, van Moorsel CHM, Vorselaars ADM, van Es HW, van Oosterhout MFM, Grutters JC.

Respirology. 2018 Mar;23(3):311-317. doi: 10.1111/resp.13230. Epub 2017 Dec 5.

37.

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.

Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA; INJOURNEY Trial Investigators.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC.

PMID:
28889759
38.

Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.

Wagenvoort GHJ, Vlaminckx BJM, van Kessel DA, Geever RCL, de Jong BAW, Grutters JC, Bos WJW, Meek B, Rijkers GT.

Vaccine. 2017 Sep 5;35(37):4886-4895. doi: 10.1016/j.vaccine.2017.07.088. Epub 2017 Aug 9.

PMID:
28802755
39.

Sarcoidosis: Evolving Concepts.

Grutters JC.

Semin Respir Crit Care Med. 2017 Aug;38(4):391-392. doi: 10.1055/s-0037-1604191. Epub 2017 Jul 27. No abstract available.

PMID:
28750455
40.

Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.

Vestjens SMT, Wagenvoort GHJ, Grutters JC, Meek B, Aldenkamp AF, Vlaminckx BJM, Bos WJW, Rijkers GT, van de Garde EMW.

Vaccine. 2017 Jul 24;35(33):4112-4118. doi: 10.1016/j.vaccine.2017.06.049. Epub 2017 Jun 28.

PMID:
28668570
41.

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group.

Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Review.

PMID:
28664861
42.

Cardiac sarcoidosis: challenges in clinical practice.

Bakker AL, Grutters JC, Keijsers RG, Post MC.

Curr Opin Pulm Med. 2017 Sep;23(5):468-475. doi: 10.1097/MCP.0000000000000410. Review.

PMID:
28661904
43.

SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.

Wolin A, Lahtela EL, Anttila V, Petrek M, Grunewald J, van Moorsel CHM, Eklund A, Grutters JC, Kolek V, Mrazek F, Kishore A, Padyukov L, Pietinalho A, Ronninger M, Seppänen M, Selroos O, Lokki ML.

Front Immunol. 2017 Apr 19;8:422. doi: 10.3389/fimmu.2017.00422. eCollection 2017.

44.

Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections.

van Kessel DA, Hoffman TW, van Velzen-Blad H, Zanen P, Grutters JC, Rijkers GT.

EBioMedicine. 2017 Apr;18:254-260. doi: 10.1016/j.ebiom.2017.03.025. Epub 2017 Mar 21.

45.

Within-day test-retest reliability of the 6-min walk test in patients with pulmonary fibrosis.

Bloem AE, Veltkamp M, Custers JW, Dolk HM, Grutters JC, Spruit MA.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601907. doi: 10.1183/13993003.01907-2016. Print 2017 Feb. No abstract available.

46.

High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.

Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Ten Berg JM, Noordzij PG, Van de Garde EMW, Bos WJW; Ovidius Study Group.

Respirology. 2017 Jul;22(5):1000-1006. doi: 10.1111/resp.12996. Epub 2017 Feb 21.

PMID:
28221010
47.

Long-term Follow-up of Humoral Immune Status in Adult Lung Transplant Recipients.

van Kessel DA, Hoffman TW, Kwakkel-van Erp JM, Oudijk ED, Zanen P, Rijkers GT, Grutters JC.

Transplantation. 2017 Oct;101(10):2477-2483. doi: 10.1097/TP.0000000000001685.

PMID:
28198768
48.

Immune status assessment in adult lung transplant candidates.

van Kessel DA, Hoffman TW, van Velzen-Blad H, van de Graaf EA, Grutters JC, Rijkers GT.

Transpl Immunol. 2017 Feb;40:31-34. doi: 10.1016/j.trim.2016.11.001. Epub 2016 Nov 17.

PMID:
27867073
49.

YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.

Spoorenberg SM, Vestjens SM, Rijkers GT, Meek B, van Moorsel CH, Grutters JC, Bos WJ; Ovidius Study Group.

Respirology. 2017 Apr;22(3):542-550. doi: 10.1111/resp.12924. Epub 2016 Oct 26.

50.

Case 8-2016: A Man with Recurrent Fevers, Hypoxemia, and Lung Infiltrates.

Hoffman TW, Grutters JC.

N Engl J Med. 2016 Jul 28;375(4):392. doi: 10.1056/NEJMc1604864. No abstract available.

PMID:
27464218

Supplemental Content

Loading ...
Support Center